Skip to main content
. 2022 Jun 30;24(6):986–994. doi: 10.1007/s11307-022-01749-7

Table 1.

Patient characteristics

Overall (n = 15)
Age
Median [Min, Max] 66.0 [37.0, 82.0]
Sex
Male 12 (80.0%)
Female 3 (20.0%)
BMI
Mean (SD) 25.2 (6.61)
Median [Min, Max] 23.3 [14.8, 40.2]
Primary tumor site
Nasopharynx 3 (20.0%)
Oropharynx 8 (53.3%)
Hypopharynx 1 (6.7%)
Larynx 3 (20.0%)
Histology
Adeno 1 (6.7%)
Squamous 14 (93.3%)
HPV status
Negative 7 (46.7%)
Positive 5 (33.3%)
Not reported 3 (20.0%)
Treatment
Chemoradiotherapy (CRT) 9 (60.0%)
Radiotherapy & Antibody therapy 4 (26.7%)
Radiotherapy (RT) 2 (13.3%)

BMI body mass index, HPV human papilloma virus